{"id":4162,"date":"2023-03-22T13:48:53","date_gmt":"2023-03-22T12:48:53","guid":{"rendered":"https:\/\/www.sgmo.ch\/?page_id=4162"},"modified":"2025-10-07T17:11:01","modified_gmt":"2025-10-07T15:11:01","slug":"spap","status":"publish","type":"page","link":"https:\/\/www.sgmo.ch\/fr\/politique\/spap\/","title":{"rendered":"SPAP"},"content":{"rendered":"<div  class='flex_column av-70mwhb-a4b789ad8311341858dd77f2c974b8f2 av_one_full  avia-builder-el-0  el_before_av_one_full  avia-builder-el-first  first flex_column_div  '     ><style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-lfjokzvk-1ff6880282b6136a098156b636f3a530\">\n#top .av-special-heading.av-lfjokzvk-1ff6880282b6136a098156b636f3a530{\npadding-bottom:0;\n}\nbody .av-special-heading.av-lfjokzvk-1ff6880282b6136a098156b636f3a530 .av-special-heading-tag .heading-char{\nfont-size:25px;\n}\n.av-special-heading.av-lfjokzvk-1ff6880282b6136a098156b636f3a530 .av-subheading{\nfont-size:15px;\n}\n<\/style>\n<div  class='av-special-heading av-lfjokzvk-1ff6880282b6136a098156b636f3a530 av-special-heading-h3  avia-builder-el-1  avia-builder-el-no-sibling '><h3 class='av-special-heading-tag '  itemprop=\"headline\"  >SPAP<\/h3><div class=\"special-heading-border\"><div class=\"special-heading-inner-border\"><\/div><\/div><\/div><\/div>\n<div  class='flex_column av-55vcpb-5a56a79bcc578628743abf8424f1c204 av_one_full  avia-builder-el-2  el_after_av_one_full  avia-builder-el-last  first flex_column_div  column-top-margin'     ><p><section  class='av_textblock_section av-lhyuiafu-4e37567cdf124e0c3c6565bb3e5cf359 '   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/CreativeWork\" ><div class='avia_textblock'  itemprop=\"text\" ><p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-4122\" src=\"https:\/\/www.sgmo.ch\/wp-content\/uploads\/SGMO-SPAP-300x116.jpg\" alt=\"\" width=\"238\" height=\"92\" srcset=\"https:\/\/www.sgmo.ch\/wp-content\/uploads\/SGMO-SPAP-300x116.jpg 300w, https:\/\/www.sgmo.ch\/wp-content\/uploads\/SGMO-SPAP-768x298.jpg 768w, https:\/\/www.sgmo.ch\/wp-content\/uploads\/SGMO-SPAP-705x273.jpg 705w, https:\/\/www.sgmo.ch\/wp-content\/uploads\/SGMO-SPAP.jpg 867w\" sizes=\"auto, (max-width: 238px) 100vw, 238px\" \/><\/p>\n<p>La SSOM \u00e0 lanc\u00e9 en 2023 le Swiss Patient Access Program (SPAP) dans le prolongement du projet pilote SPAP (voir ci-dessous). Les objectifs du SPAP sont les suivants :<\/p>\n<ul>\n<li>Eviter\/r\u00e9duire les cas de rigueur dans le traitement de demandes en vertu de l&rsquo;art. 71 a-d OAMal<\/li>\n<li>Proposer une solution aux cas de rigueur en faisant appel \u00e0 des experts m\u00e9dicaux<\/li>\n<li>Etablir des preuves sur la base desquelles les experts peuvent prendre des d\u00e9cisions \u00e0 l&rsquo;aide d&rsquo;une check-list d&rsquo;\u00e9valuation standardis\u00e9e<\/li>\n<li>Estimer le b\u00e9n\u00e9fice pour le patient sur la base des donn\u00e9es de sant\u00e9 collect\u00e9es de mani\u00e8re routini\u00e8re<\/li>\n<li>Les conclusions du SPAP doivent \u00eatre int\u00e9gr\u00e9es \u00e0 l&rsquo;outil OLU<\/li>\n<\/ul>\n<p>Vers le projet pilote SPAP: En collaboration avec des partenaires industriels, la SSOM a lanc\u00e9 le projet pilote SPAP \u00e0 l&rsquo;\u00e9chelle nationale pour une premi\u00e8re phase pilote courant d&rsquo;avril 2019 \u00e0 d\u00e9cembre 2022 dans le but de fournir rapidement \u00e0 tous les patients atteints d&rsquo;un cancer un acc\u00e8s \u00e9quitable aux th\u00e9rapies m\u00e9dicalement indiqu\u00e9es. Un dialogue commun avec tous les acteurs du syst\u00e8me de sant\u00e9 suisse devrait permettre de d\u00e9velopper \u00e0 long terme des solutions visant \u00e0 am\u00e9liorer la r\u00e9mun\u00e9ration au cas par cas conform\u00e9ment \u00e0 l&rsquo;art. 71 a-d OAMal.<\/p>\n<p><a href=\"https:\/\/www.spap.health\/fr\/\" target=\"_blank\" rel=\"noopener\">Site web SPAP<\/a><\/p>\n<p><strong>Le SPAP dans les news :<\/strong> Le Tages-Anzeiger a publi\u00e9 un article sur le SPAP le 7 octobre 2025. <a href=\"https:\/\/www.bazonline.ch\/schweiz-krankenkasse-lehnte-teure-krebsmedikamente-ab-304011833676\" target=\"_blank\" rel=\"noopener\">Vous pouvez lire l\u2019article ici<\/a>.<\/p>\n<\/div><\/section><br \/>\n<div  class='hr av-2diiz3-28a0cbd6b7883bdcb0a06fa3dbee6b1b hr-default  avia-builder-el-4  el_after_av_textblock  avia-builder-el-last '><span class='hr-inner '><span class=\"hr-inner-style\"><\/span><\/span><\/div><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":4154,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-4162","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.sgmo.ch\/fr\/wp-json\/wp\/v2\/pages\/4162","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sgmo.ch\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.sgmo.ch\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.sgmo.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sgmo.ch\/fr\/wp-json\/wp\/v2\/comments?post=4162"}],"version-history":[{"count":6,"href":"https:\/\/www.sgmo.ch\/fr\/wp-json\/wp\/v2\/pages\/4162\/revisions"}],"predecessor-version":[{"id":12056,"href":"https:\/\/www.sgmo.ch\/fr\/wp-json\/wp\/v2\/pages\/4162\/revisions\/12056"}],"up":[{"embeddable":true,"href":"https:\/\/www.sgmo.ch\/fr\/wp-json\/wp\/v2\/pages\/4154"}],"wp:attachment":[{"href":"https:\/\/www.sgmo.ch\/fr\/wp-json\/wp\/v2\/media?parent=4162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}